Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 23;16(1):26.
doi: 10.5334/gh.973.

Research Letter: Unmet Need for Hypertension Treatment in India: Evidence from Hypertension Drugs Market Data

Anupam Khungar Pathni  1 , Swagata Kumar Sahoo  1 , Andrew E Moran  1   2 , Jennifer Cohn  1   3 , Sanchit Bhatia  4 , Nilesh Maheshwari  4 , Bhawna Sharma  1
Affiliations

Research Letter: Unmet Need for Hypertension Treatment in India: Evidence from Hypertension Drugs Market Data

Anupam Khungar Pathni et al. Glob Heart. .
No abstract available

Keywords: hypertension drugs; hypertension treatment; public health.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests to declare.

References

    1. Gupta R, Gaur K, Ram CVS. Emerging trends in hypertension epidemiology in India. Journal of Human Hypertension. 2018; 33(8): 575–587. DOI: 10.1038/s41371-018-0117-3 - DOI - PubMed
    1. Government of India. Key Indicators of Social Consumption in India – Health. NSS 75th Round. July 2017–June 2018. Ministry of Statistics and Programme Implementation. Kolkata, India: National Sample Survey Office; 2019. Retrieved from: http://mospi.nic.in/sites/default/files/publication_reports/KI_Health_75....
    1. IQVIA. Antihypertensive medicines market in India: Analysis of IQVIA sales dataset for India and five states from 2016–2018. Report submitted to Resolve to Save Lives (unpublished); 2020.
    1. Geldsetzer P, Manne-Goehler J, Theilmann M, Davies JI, Awasthi A, Vollmer S, et al. Diabetes and hypertension in India a nationally representative study of 1.3 million adults. JAMA Intern Med. 2018; 178(3): 363–372. DOI: 10.1001/jamainternmed.2017.8094 - DOI - PMC - PubMed
    1. World Health Organization. WHO International Working Group for Drug Statistics Methodology, WHO Collaborating Centre for Drug Statistics Methodology, WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services, Introduction to Drug Utilization Research. Oslo, Norway: WHO; 2003. Retrieved from: https://apps.who.int/iris/handle/10665/42627.

Publication types

Substances